Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

33

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

Tags:

Previous Article

Timescapes of non-human experience

Parkinson's medication shows promise in treating depression

Related Posts

Long-lived cellular molecules in the brain

Long-lived cellular molecules in the brain

122

Stimulant medications affect arousal and reward, not attention networks

Stimulant medications affect arousal and reward, not at...

73

Complement C3aR deletion does not attenuate degeneration in a tauopathy model or alter acute inflammation-induced gene expression changes

Complement C3aR deletion does not attenuate degeneratio...

43